Sugi Predict

Sugi Predict / Compounds / SCHEMBL277792

SCHEMBL277792

SCHEMBL277792

CCCCCCC(C=O)CCC

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 3/20 0.60
▸ SMN1; SMN2 Q16637 1/20 0.60
▸ ADH1B P00325 2/20 0.47
▸ ADH1C P00326 2/20 0.47
▸ ADH1A P07327 2/20 0.47
▸ ADH4 P08319 2/20 0.47
▸ ADH7 P40394 2/20 0.47
▸ MAPT P10636 2/20 0.41
▸ TRPA1 O75762 1/20 0.41
▸ DDAH1 O94760 1/20 0.41
▸ GAPDH P04406 1/20 0.41
▸ GPR84 Q9NQS5 3/20 0.40
▸ FDPS P14324 3/20 0.40
▸ FFAR1 O14842 1/20 0.40
▸ EPHX1 P07099 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ LCK P06239 1/20 0.39
▸ PPARD Q03181 1/20 0.39
▸ ZDHHC20 Q5W0Z9 1/20 0.39
▸ ZDHHC2 Q9UIJ5 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27721392 1.00 TSHR (0.60) TSHRSMN1; SMN2ADH1BADH1CADH1A
SCHEMBL2927576 1.00 TSHR (0.60) TSHRSMN1; SMN2ADH1BADH1CADH1A
SCHEMBL28625479 1.00 TSHR (0.60) TSHRSMN1; SMN2ADH1BADH1CADH1A
SCHEMBL29291468 1.00 TSHR (0.60) TSHRSMN1; SMN2ADH1BADH1CADH1A
SCHEMBL9320445 1.00 TSHR (0.60) TSHRSMN1; SMN2ADH1BADH1CADH1A
SCHEMBL29291465 1.00 TSHR (0.60) TSHRSMN1; SMN2ADH1BADH1CADH1A
SCHEMBL6925908 1.00 TSHR (0.60) TSHRSMN1; SMN2ADH1BADH1CADH1A
SCHEMBL28625631 1.00 TSHR (0.60) TSHRSMN1; SMN2ADH1BADH1CADH1A
SCHEMBL2925442 1.00 TSHR (0.60) TSHRSMN1; SMN2ADH1BADH1CADH1A
SCHEMBL547296 0.98 TSHR (0.62) TSHRSMN1; SMN2ADH1BADH1CADH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230233425-A1 USE OF VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE THE PERCEPTION OF MALODOR FIRMENICH SA (CH) 2023-07-27 — — US claimed
CN-113573592-A Oral cavity coating feeling enhancer 味之素株式会社 2021-10-29 — — CN claimed
WO-2020184682-A1 MOUTH-COATING FEEL ENHANCER 味の素株式会社 2020-09-17 — — WO claimed
EP-3697456-A1 MALODOR COUNTERACTING INGREDIENTS Firmenich SA (CH) 2020-08-26 — — EP claimed
WO-2019101813-A1 MALODOR COUNTERACTING INGREDIENTS FIRMENICH SA (CH) 2019-05-31 — — WO claimed
CN-103335964-A Carbonyl compound analysis method in after-treatment technique process CHINA INST ATOMIC ENERGY 2013-10-02 — — CN claimed
US-12600926-B2 Treatment compositions with modified amino acid dimers for delivering a benefit agent THE PROCTER & GAMBLE COMPANY (US) 2026-04-14 — — US disclosed
WO-2025245043-A1 BRANCHED DERIVATIVES SCION Holdings LLC (US) 2025-11-27 — — WO disclosed
US-20250327793-A1 METHODS OF IDENTIFYING COMPOUNDS THAT MODULATE LAUNDRY MALODOR, MOLDY MALODOR, OR SWEAT MALODOR FIRMENICH SA (CH) 2025-10-23 — — US disclosed
CN-111601786-B Branched trialkylamine precursors, intermediates, products made therefrom and methods of making 伊士曼化工公司 2024-03-12 — — CN disclosed
CN-117562239-A Coated mouth feel enhancer 味之素株式会社 2024-02-20 — — CN disclosed
US-11744785-B2 Use of volatile compositions to limit or eliminate the perception of malodor FIRMENICH SA (CH) 2023-09-05 — — US disclosed
US-20230233425-A1 USE OF VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE THE PERCEPTION OF MALODOR FIRMENICH SA (CH) 2023-07-27 — — US disclosed
US-4922028-A Process for the hydroformylation of sulfur-containing thermally cracked petroleum residue and novel products thereof EXXON RESEARCH & ENGINEERING COMPANY (US) 1990-05-01 — — US disclosed
EP-0329670-A1 A PROCESS FOR THE HYDROFORMYLATION OF SULFUR-CONTAINING THERMALLY CRACKED PETROLEUM RESIDUA AND NOVEL PRODUCTS THEREOF. EXXON RESEARCH ENGINEERING CO (US) 1989-08-30 — — EP disclosed
EP-0329670-A4 A PROCESS FOR THE HYDROFORMYLATION OF SULFUR-CONTAINING THERMALLY CRACKED PETROLEUM RESIDUA AND NOVEL PRODUCTS THEREOF. EXXON RESEARCH ENGINEERING CO (US) 1989-08-16 — — EP disclosed
WO-1988002360-A1 A PROCESS FOR THE HYDROFORMYLATION OF SULFUR-CONTAINING THERMALLY CRACKED PETROLEUM RESIDUA AND NOVEL PRODUCTS THEREOF EXXON RESEARCH AND ENGINEERING COMPANY (US) 1988-04-07 — — WO disclosed
US-4711968-A PRODUCTION OF ALDEHYDES AND ALCOHOLS USING TRANSITION METAL CARBONYL COMPLEX CATALYSTS EXXON RESEARCH & ENGINEERING CO. (US) 1987-12-08 — — US disclosed
US-4052461-A ALDEHYDES FROM OLEFINS, CARBON MONOXIDE AND HYDROGEN, RHODIUM CATALYST MONSANTO COMPANY (US) 1977-10-04 — — US disclosed
US-3984478-A TREATING AN UNSATURATED COMPOUND WITH CARBON MONOXIDE IN A HETEROGENEOUS CATALYST UNIVERSAL OIL PRODUCTS COMPANY (US) 1976-10-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11744785-B2 Use of volatile compositions to limit or eliminate the perception of malodor TAS2R8, TRPA1, TAS2R10 TSHR 2144/4885SMN1; SMN2 1562/4885ADH1B 1371/4885
US-12600926-B2 Treatment compositions with modified amino acid dimers for delivering a benefit agent F2, C9, S100A8 TSHR 4589/4885SMN1; SMN2 984/4885ADH1B 3038/4885
US-20230233425-A1 USE OF VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE THE PERCEPTION OF MALODOR TAS2R8, TRPA1, TAS2R10 TSHR 2144/4885SMN1; SMN2 1562/4885ADH1B 1371/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.